RCM Week 4 ( Atrial Fibrillation) Flashcards
Where are spontaneously firing cells located and what are their spontaneous discharge rates
1) SA node (right atrial wall near opening of superior vena cava) 70-80 action potentials / min
2) AV node (base of right atrium near septum, just above A-V junction) 40-60 action potentials / min
3) bundle of His, bundle branches, purkinje fibres 20-40 action potentials / min
What is the order that excitation spreads in a coordinated manner through the specialised conducting tissue
- SA node (pacemaker)
- Rapidly through atria (1m/sec)
- AV node (0.05 m/sec)
- Rapidly through bundle of His and down the bundle branches and purkinje fibres (1-4 m/sec)
- Through the ventricular muscle cells
What facilitates the rapid spread of excitation through the heart
Intercalated discs between the fibres
What is the role of gap junctions
Provide low resistance pathways and therefore cardiac muscle functions as a syncitium (single unit)
How is efficient emptying of blood from atria to ventricles enabled
Co-ordination of the spread of excitation means that atrial excitation and contraction are complete before ventricular contraction (due to AV delay)
Describe the role of calcium is excitation-contraction coupling
- Influx of Ca2+ during action potential
- triggers release of further Ca2+ from sarcoplasmic reticulum
- free Ca2+ activates contraction of myocardial fibres (systole)
- amount of Ca2+ determines cross bridge cycling and force of contraction
- uptake of Ca2+ by sarcoplasmic reticulum and extrusion of Ca2+ by Na+ / Ca2+ exchange and outward Ca2+ pump
- lowers free Ca2+ allowing relaxation (diastole)
Which direction does ventricular excitation / contraction occur from
- endocardium to epicardium and
- apex to base
What does an electrocardiogram measure
Electrical activity of the heart (depolarisation and repolarisation) recorded from electrodes positioned on the surface of the body (the electrocardiograph is the recorder)
What does an ECG provide information about
1) timing and direction of cardiac events: atrial and ventricular depolarisation, ventricular repolarisation
2) rate/ rhythm disturbances : tachycardia / bradycardia ; sinus rhythm; arrhythmia
3) conduction abnormalities : A-V conduction time
4) mass of active myocardium :
Ischaemic areas
Rules of interpreting an electrocardiogram
1) depolarisation moving towards a positive electrode gives an upward deflection
2) depolarisation moving away from a positive electrode gives a downward deflection
3) amplitude is maximal when the positive electrode is not the vector and minimal / biphasic when perpendicular
4) depolarisation moving towards a negative electrode gives a downward deflection
5) depolarisation moving away from a negative electrode gives an upward deflection ie a vocally positioned negative electrode records the same thing as a diametrically opposite positive electrode
What are the 3 essential parts of the electrocardiograph
1) an amplifier - magnifies the small potential differences produced by the electrical activity of the heart and manifest at the surface of the body
2) recording system - gives a visual display and / or permanent record of these potential changes
3) selector- allows records to be taken from various combinations of electrodes
What does an ECG do
Examines the coordination of excitation within the heart by the changes in electrical potential at the body surface caused by the electrical activity of the heart
What is on the x and y axis of the ECG trace
Y axis: amplitude
X axis: time
This allows us to measure the interval between ECG waves (using the R waves) and hence calculate heart rate
Where are the ECG electrodes placed and what colour corresponds with each position
Right arm = white
Left arm = black
Right leg = green
Left leg = red
Can be placed on the ankles and wrists or the legs and shoulders and will give the same signal as any activity reaching the wrists / ankles must also pass through the shoulders / legs
What is a 12 lead ECG and where are the additional 6 electrodes placed
It is much more common for patients to undergo a 12 lead ECG, where an additional 6 unipolar recording electrodes are positioned on the chest.
Placed as follows:
V1- fourth intercostal space at the right margin of the sternum
V2- fourth intercostal space at left margin of sternum
V3- midway between position 2 and 4
V4- fifth intercostal space at junction of midclavicular line
V5- at horizontal level of position 4 at left anterior axillary line
V6- at horizontal level of position 4 at mid-axillary line
What does atrial fibrillation look like on an ECG
Absence of p waves and irregularly irregular QRS complex.
Absence of p waves shows abnormal atrial depolarisation and an irregular QRS complex is caused by abnormal depolarisation of ventricles
What is fibrinolysis
The breakdown of a clot
What is warfarin
An oral anticoagulant
Prevents unwanted thrombosis
Vitamin K antagonist
Why is warfarin a vitamin k antagonist
Vitamin k is essential for production of prothrombin and for post ribosomal carboxylation of glutamic acid residues for these proteins
Warfarin blocks vit K reductase needed for vit K to act as a cofactor
Why do patients with replaced heart valves need warfarin
To prevent clot formation
Why is warfarin difficult to use
If conc is slightly too high can lead to bleeding so must be monitored by monitoring the INR with a specific target value and adjust the dose
- do this by regularly blood testing the patient
Can cause cerebral, gastric bleeding, coughing up blood, blood in urine or faeces or easy bruising
- also has lots of drug interactions
Macrolides prevent the breakdown of warfarin- patient is more likely to bleed - may be reduced by enzyme inducers
Examples of injectable anticoagulants
Unfractionated heparin or LMWHs (eg enoxaparin, tinzaparin- much easy to use and don’t need monitoring as closely as heparins)
- activate antithrombin III (natural protein)
- antithrombin - inactivated some clotting factors and thrombin by complexing with serine protease of the factors
What can you do if patient is given too much warfarin
Vit K injection which quickly reverses the effects
What is heparin
Acts almost immediately (unlike warfarin which takes a few days)
- used to prevent thrombosis (venous unstable angina) and used to prevent blood clotting on collection
- used while warfarin takes effect
- unfractionated heparin monitored by APTT
What are direct oral anticoagulants (DOACs)
Dabigatran: an oral thrombin inhibitor
- prevents thromboembolism:
- less bleeding than warfarin
- fewer drug interactions
- does not require monitoring
What is prostacyclin
A prostaglandin produced by platelets both endothelial cells that line blood vessels - derived vasodilators
What does PGI2 and thromboxane do
PGI2- prevents platelet aggregation- acts on platelets to increase cAMP
Thromboxane - promotes aggregation, decreases cAMP
What does nitric oxide do
Prevents both platelet adhesion and aggregation by increasing platelet cGMP
How does low dose aspirin work as an anti platelet drug
75mg
- used to prevent MI in patients who have previously had an MI
- recommended for secondary but not primary prevents
- reduces incidence of stroke
- inhibits cycle-oxygenase (irreversible)
- rarely used as a painkiller nowadays due to the stomach effects
Why does aspirin favour PGI2 over TXA2
Because platelets have no nuclei - cant produce any more cycle-oxygenase (COX) - no more TXA2 until new platelets are synthesised (7 days)
- endothelial cells have nuclei and can produce more COX
What is dipyridamole
Antiplatelet drug
- phosphodiesterase inhibitor - prevents breakdown of cAMP and cGMP (which are broken down by phosphodiesterases)
- used to prevent thrombosis
- also inhibits adenosine uptake
- used in conjunction with aspirin
Study found dipyridamole plus aspirin is more effective than aspirin alone in prevention of cerebral ischaemia of arterial origin
What is glycoproteins IIb / IIIa
ADP from aggregating platelets leads to expression of glycoproteins IIb/ IIIa
GP IIb / IIIa - binds fibrinogen which leads to cross linking of platelets
What is clopidogrel
Inhibits ADP- induced expression of glycoprotein. For patients who cant take aspirin - similarity effective / safe
- recent CURE trial indicated that clopidogrel plus aspirin greatly reduced MIs in patients at risk
- is used in combination with aspirin
What is abciximab (antiplatelet)
Monoclonal antibody against GP IIb / IIa
- given to patients undergoing angioplasty (only use once)
Cannula inserted into radial artery - open coronary artery with balloon and insert stent
What are thrombolytics
Used in thromboembolic stroke to dissolve clots with reperfusion
- alteplase licensed for ischaemic stroke
Give immediately after an MI- dissolve thrombus that has caused blockage of coronary arteries and the MI (emergency angioplasty is now the primary treatment)
Also used for pulmonary embolism - best given with aspirin but can cause bleeding
What is reperfusion
Restoring blood flow after a heart attack or stroke
What is haemostasis
The stopping of the flow of blood by coagulation and platelet processes
What are clotting mechanisms
Intrinsic - exposed collagen from injured blood vessel wall
Extrinsic - damaged tissue releases thromboplastin
What are platelets
Non nuclear cellular fragments
Form mechanical plugs during blood vessel injury
- adhesion and aggregation reactions :
- adhesion: to subendothelial surface on damage / disease- due to binding to Von WIllebrand’s factor
- adhesion causes release reaction: ADP and thromboxane which promote platelet aggregation
What do aggregation and adhesion reactions of platelets lead to
Leads to platelet mass to plug area of endothelial damage
Promotes coagulation reaction: -ve charged phospholipids non activated platelets which have adhered to site of damage localise fibrin formation
How can you assess if there is any dysfunction to clotting
1) bleeding time
- incisions to forearm with venous cuff
- increased in platelet dysfunction / thrombocytopenia
2) prothrombin time (international normalised ratio INR)
- time for coagulation following addition of thromboplastin
- prolonged by abnormalities of factors VII, X, V, II or I, liver disease or warfarin
3) activated partial thromboplastin time (APTT)
- examines intrinsic pathway
- altered by changes in factors XII, XI, IX, VIII, X, V, II or I
What happens to INR in someone with liver disease
They produce less coagulation factors and so INR rises
Disorders of clotting and bleeding
Thrombosis- unwanted blood clots
Venous- clots (thrombi) form in veins (DVT) due to stasis of blood, may travel to lungs - pulmonary embolism ‘Economy class syndrome’
Atrial fibrillation- risk of TIA (transient ischaemic attack) or stroke)
What happens to the heart in atrial fibrillation
The atria are diseased, stretched, fibrosed and this stops the SAN from being the pacemaker of the heart and instead you get multiple pacemakers meaning there is no coordinated contraction and this means clots can from in the atria.
In the left atria this can break off and lead to a cardiembolic stroke and in the right atria this would lead to a pulmonary embolism
What is arterial thrombosis
Arterial: form at atherosclerotic sites and lead to arterial blockage:
- heart attack
- cerebral vessels (stroke)
Biggest killer in the western world at the moment
Describe the atherosclerosis timeline
- Foam cells
- Fatty streak
- Intermediate lesion
- Atheroma
- Fibrous plaque
- Complicated lesion / rupture
What is haemophilia A
Genetic condition - carried on X chromosome, so males (XY) are most affected and females (XX) are carriers
- low or lacking factor VIII of the clotting cascade
- haemorrhage and prolonged bleeding (eg after tooth extraction)
- treat with factor VIII from blood donors or analogue of vasopressin (ADH) which increases patients factor VIII release
What is emicizumab
A monthly subcutaneous injection for patients with haemophilia A instead of daily infusions of factor VIII
- bispecific MAB: binds to activated factor IX and X
- very effective at reducing bleeds
30% of patients with haemophilia A treated with factor VIII develop resistance due to the inhibitory factors produced
What is haemophilia B
Deficiency of factor IX
Treated with prophylactic factor IX